SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-12-014949
Filing Date
2012-03-14
Accepted
2012-03-14 17:20:28
Documents
1
Group Members
JULIET TAMMENOMS BAKKERLONGITUDE CAPITAL ASSOCIATES, L.P.LONGITUDE VENTURE PARTNERS, L.P.PATRICK G. ENRIGHT

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO SCHEDULE 13D v305884_13da.htm SC 13D/A 98062
  Complete submission text file 0001144204-12-014949.txt   99758
Mailing Address 45 FITZWILLIAM SQUARE DUBLIN L2 2
Business Address 45 FITZWILLIAM SQUARE DUBLIN L2 2 353-1-634-4183
Jazz Pharmaceuticals plc (Subject) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82922 | Film No.: 12691131
SIC: 2834 Pharmaceutical Preparations

Mailing Address 800 EL CAMINO REAL SUITE 220 MENLO PARK CA 94025
Business Address 800 EL CAMINO REAL SUITE 220 MENLO PARK CA 94025 650-854-5700
Longitude Capital Partners, LLC (Filed by) CIK: 0001430720 (see all company filings)

IRS No.: 261165932
Type: SC 13D/A